Misoprostol, a Prostaglandin E1 analog, for prelabour ripening of the unfavourable uterine cervix

Fetal and Maternal Medicine Review

Volumn 8, Issue 4, 1996, Pages 217-227

  Ramsey, Patrick S ^a   Ramin, Kirk D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; OXYTOCIN; PROSTAGLANDIN E1 DERIVATIVE; PROSTAGLANDIN E2;

CLINICAL TRIAL; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; HUMAN; LABOR INDUCTION; REVIEW; UTERINE CERVIX RIPENING;

EID: 0030425780     PISSN: 09655395     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0965539596000034     Document Type: Article

References (59)

1. Clinton. The Clinton health care plan. N Engl J Med 1992; 327: 804-7.
2. American College of Obstetricians and Gynecologists. Induction and augmentation. ACOG Technical Bulletin No. 110. Washington DC American College of Obstetricians and Gynecologists, 1987.
3. Brown CEL, Satin AJ, Leveno KJ. The economic advantages of measured change in health care: An example from obstetrics. Obstet Gynecol 1994; 84: 893-95.
4. Hayashi RH. Spontaneous and induced cervical ripening: Natural dilation and effacement process and current cervical ripening techniques. J Reprod Med 1993; 38 (Suppl1): 66-72.
5. Mastrogiannis DS and Knuppel RA. Labour induced using methods that do not involve oxytocin. Clin Obstet Gynecol 1995; 38: 259-66.
6. Krammer J and O'Brien WF. Mechanical methods of cervical ripening. Clin Obstet Gynecol 1995; 38: 280-86.
7. Keirse MJNC. Prostaglandins in preinduction cervical ripening: Meta-analysis of worldwide clinical experience. J Reprod Med 1993; 38 (Supl 1): 89-100.
8. Danforth DN. The morphology of the human cervix. Clin Obstet Gynecol 1983; 26: 7-13.
9. Anderson ABM, Flint APF, and Turnbull AC. Mechanism of action of glucocorticoids in induction of ovine parturition: Effect on placental steroid metabolism. J Endocrinol 1975; 66: 61-70.
10. 1 alpha gradients across the uterus in women in labour and not in labour. Am J Obstet Gynecol 1987; 157: 54-58.
11. Abel MH Baird DT. The effect of 17 beta-estradiol and progesterone on prostalandin production by human endometrium maintained in organ culture. Endocrinology 1980; 106: 1599-606.
12. Uldbjerg N, Ulmesten U Ekman G. The ripening of the human uterine cervix in terms of connective tissue biochemistry. Clin Obstet Gynecol 1983; 26:14-26.
13. Theobald PW, Rath W, Kuhnle H Kuhn W. Histological and electron-microscopic examinations of collagenous connective tissue of the non-pregnant cervix, the pregnant cervix and the pregnant prostaglandin-treated cervix. Arch Gynecol 1982; 231: 241-45.
14. 2. Gynecol Obstet Invest 1983; 15: 291-99.
15. Danforth DN, Buckingham JC, Roddick JW. Connective tissue changes incident to cervical effacement. Am J Obstet Gynecol 1960; 80: 939.
16. Danforth DN, Veis A, Breen M, Weinstein HG, Buckingham JC, Manalo P. The effect of pregnancy and labor on the human cervix: Changes in collagen glycoproteins and glycosaminoglycans. Am J Obstet Gynecol 1974; 120: 641-51.
17. Von Maillot K, Stuhlsatz HW, Mohanaradhakrishnan V, Greiling H. Changes in the glycosaminoglycans distribution pattern in the human uterine cervix during pregnancy and labor. Am J Obstet Gynecol 1979; 135: 503-506.
18. Hayashi RH. Cervical ripening: Advances in preinduction of labor. J Reprod Med 1993; 38: 83-8.
19. 2 preparations for preinduction cervical ripening: Pharmacy considerations. J Repro Med 1993; 38: 83-8.
20. 2 pessary for cervical ripening and initiation of labor at term. Obstet Gynecol 1992; 79: 374-79.
21. 2 in a controlled-release vaginal pessary for cervical ripening at term. Am J Obstet Gynecol 1992; 146: 830-34.
22. 2 gel. Acta Obstet Gynecol Scand 1987; 66: 3-7.
23. 2 (Prepidil) gel. Am J Obstet Gynecol 1985; 153: 268-71.
24. 2-gel. Int J Gynaecol Obstet 1986; 24: 297-300.
25. 2 (Prepidil) gel. J Perinatol 1987; 7: 189-93.
26. Physicians Desk Reference - 50th Edition. Medical Economics Co., Montvale, New Jersey: 1994: 2424-26.
27. Product information. Cytotec. GD Searle and Co. 1991.
28. 1 methyl analog misoprostol on the pregnant uterus in the first trimester. Geburtshilfe und Frauenheilkunde 1987; 47: 324-31.
29. Normam JE, Thong KJ, Baird DT. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet 1991; 338: 1233-36.
30. 1: A review. Prostaglandins Leukotrienes and Essential Fatty Acids Review 1988; 32: 165-74.
31. Collins PW, Pappo R Dajani EZ. Chemistry and synthetic development of misoprostol. Digest Dis Sci 1885; 30: 114-17.
32. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation, 4th edition. Baltimore MD: Williams and Wilkins Inc, 1994: 601-603.
33. 1 methyl analogue misoprostol: A randomized 4 controlled trial. J Obstet Gynaecol Res 1996; 22: 119-24.
34. Curtis P, Evens S, Resnick J. Uterine hyperstimulation. The need for standard 4 terminology. J Reprod Med 1987; 32: 91-3.
35. Fletcher HM, Mitchell S, Simeon D, Frederick J Brown D. Intravaginal misoprostol as a cervical ripening agent. Br J Obstet Gynecol 1993; 100: 641-44.
36. 1 methyl analogue misoprostol versus oxytocin: A randomized trial. Obstet Gynecol 1993; 81: 332-36.
37. Margulies M, Campos G Voto LS. Misoprostol to induce labour [letter]. Lancet 1992; 339: 64.
38. 1 analog for induction of labor at term: comparative and | randomized study with oxytocin. Revista Chilena Obstet Ginecol 1994; 59: 190-95.
39. 2 gel for preinduction cervical ripening and labor induction. Am J Obstet Gynecol 1995; 172: 1804-10.
40. Wing DA, Rahall A, Jones MM, Goodwin TM Paul RH. Misoprostol: An effective agent for cervical ripening and labor induction. Am J Obstet Gynecol 1995; 172: 1811-6.
41. 2 gel for induction of labor at term. Obstet Gynecol 1995; 86: 541-44.
42. 2 gel (Prepidil gel): Randomized comparison. Am J Obstet Gynecol 1995; 173: 1137-42.
43. Magtibay PM, Harris DY, Suman V, Ogburn PL Jr, Ramin KD. Misoprostol as a labor inducing agent: A pilot study comparing efficacy, safety and cost. Society of Perinatal Obstetricians Annual Meeting, Kamuela, HI: Feb. 5-10, 1996
44. Magtibay PM, Ramin KD, Harris DY, Ramsey PS, Ogburn PL Jr. Misoprostol as a labor inducing agent: A pilot study comparing efficacy, safety and cost. Manuscript submitted.
45. Fletcher H, Mitchell S, Frederick J, Simeon D, Brown D. Intravaginal misoprostol versus dinoprostone as cervical ripening and labor-inducing agents. Obstet Gynecol 194; 83: 244-47.
46. Ngai SW, To WK, Lao T, Ho PC. Cervical priming with oral misoprostol in pre-labor rupture of membranes at term. Obstet Gynecol 1996; 87: 923-26.
47. Rosen MG, Dickinson JC, Westhoff CL. Vaginal birth after cesarean: A meta-analysis of morbidity and mortality. Obstet Gynecol 1991; 72: 46-70.
48. Norman M, Ekman G. Preinduction cervical ripening with prostaglandin E2 in women with one previous cesarean section. Acta Obstet Gynecol Scand 1992; 71: 351-55.
49. Del Valle GO, Adair CD, Sanchez-Ramos L, Glaudier FL, McDyer DC, Delke I. Cervical ripening in women with previous cesarean deliveries Int J Gynecol Obstet 1994; 47: 17-21.
50. th Annual Meeting, Denver, CO; April 27 - May 1 1996.
51. Chez RA. Cervical ripening and labor induction after previous cesarean section. Clin Obstet Gynecol 1995; 38: 287-92.
52. Wing DA, Paul RH. A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction. Am J Obstet Gynecol 1996; 175: 158-64.
53. Sanchez-Ramos L, Kauritz AM. Intravaginal misoprostol versus dinoprostone as cervical ripening and labor-inducing agents. Obstet Gynecol 1994; 83: 799-800.
54. 1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease. J Vasc Surg 1984; 1: 160-70.
55. 1 in infants with critical congenital heart disease. Circulation 1981; 64: 893-98.
56. Kalra PA, Litherland D, Sallomi DF, Critchley HOD, Falconer GF, Hohnes AM. Cardiac standstill induced by prostaglandin pessaries. Lancet 1989; 11 (8652): 1460-61.
57. Bond GR, Van Zee A. Overdosage of misoprostol in pregnancy. Am J Obstet Gynecol 1994; 171: 561-62.
58. Norman JE. Uterine rupture during therapeutic abortion in the second trimester using mifepristone and prostaglandin. Br J Obstet Gynecol 1995; 102: 33233.
59. Phillips K, Berry C, Mathers AM. Uterine rupture during second trimester termination of pregnancy using mifepristone and a prostaglandin. Eur J Obstet Gynecol 65: 175-76.